CIK 0001821586
- Large accelerated filer
MoonLake Immunotherapeutics
Sign in to watch- Ticker
- MLTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +41 415108022
- Business address
- DORFSTRASSE 29, ZUG, Switzerland, 6300
- Former names
- Helix Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-27 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −1,100 | $20.00 | $22K | 2,711,198 |
| 2026-07-22 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −2,448 | $20.00 | $49K | 2,712,298 |
| 2026-07-21 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $20.02 | $1.0M | 2,714,746 |
| 2026-07-20 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −43,700 | $20.09 | $878K | 2,764,746 |
| 2026-07-15 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −16,105 | $20.01 | $322K | 2,808,446 |
| 2026-06-17 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $19.43 | $972K | 2,824,551 |
| 2026-06-16 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $18.70 | $935K | 2,874,551 |
| 2026-06-15 | Reich Kristian Chief Scientific Officer | Sale 10b5-1 | −50,000 | $18.89 | $945K | 2,924,551 |
| 2026-01-07 | Reich Kristian Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +520,342 | 520,342 | ||
| 2025-12-19 | Reich Kristian Chief Scientific Officer | Conversion | +35,389 | 35,389 | ||
| 2025-12-19 | Reich Kristian Chief Scientific Officer | Returned to the company | −35,389 | 0 | ||
| 2025-12-19 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,052 | 0 | ||
| 2025-12-09 | Reich Kristian Chief Scientific Officer | Sale | −72,908 | $14.43 | $1.1M | 0 |
| 2025-12-08 | Reich Kristian Chief Scientific Officer | Sale | −130,000 | $15.08 | $2.0M | 72,908 |
| 2025-09-02 | Reich Kristian Chief Scientific Officer | Conversion | +48,978 | 202,908 | ||
| 2025-09-02 | Reich Kristian Chief Scientific Officer | Returned to the company | −48,978 | 35,389 | ||
| 2025-02-27 | Reich Kristian Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +139,273 | 139,273 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG | −1,456 | 1,052 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Conversion | +111,949 | 153,930 | ||
| 2025-01-20 | Reich Kristian Chief Scientific Officer | Returned to the company | −111,949 | 84,367 |
Page 1 of 3 · 47 trades